4536:TYO
Santen Pharmaceutical Co Ltd
Â¥2,035.00
arrow_upward
+1.67%(+33.50) 1D
Nov 13, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4536...
Open
Â¥1,996
High
Â¥2,036
Low
Â¥1,973
Mkt. cap
655.91B
Avg. vol.
1.32M
Volume
1.49M
Dividend
1.97%
Quarterly dividend
Â¥10
Ex-dividend date
Sep 29, 2026
P/E ratio
16.83
52-wk high
Â¥2,254
52-wk low
Â¥1,533
EPS
Â¥121
Shares outstanding
407.09M
No. of employees
4K
Open
Â¥1,996
High
Â¥2,036
Low
Â¥1,973
Mkt. cap
655.91B
Avg. vol.
1.32M
Volume
1.49M
Dividend
1.97%
Quarterly dividend
Â¥10
Ex-dividend date
Sep 29, 2026
P/E ratio
16.83
52-wk high
Â¥2,254
52-wk low
Â¥1,533
EPS
Â¥121
Shares outstanding
407.09M
No. of employees
4K
News stories
From web sources and news partners
ChartMill
·
21 minutes ago
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Investing.com
·
1 hour ago
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Yahoo Finance
·
43 minutes ago
The S&P 500 Recently Experienced Its Worst Day Since 2025. Here's Why Investors Shouldn't Worry.
FOREX.com
·
1 hour ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3.97K
Founded1890
HeadquartersOsaka, Kansai, Japan
SectorHealth Care
IndustryPharmaceutical industry
Websitesanten.com